Oliver Grottke
Overview
Explore the profile of Oliver Grottke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
947
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Last J, Birschmann I, Lindau S, Konstantinides S, Grottke O, Nowak-Gottl U, et al.
Pharmaceuticals (Basel)
. 2025 Feb;
18(2).
PMID: 40005984
Major bleeding or emergency surgery are the most frequently observed emergency situations in patients anticoagulated with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs). The restart of anticoagulation after...
2.
Grottke O, Heubner L
Curr Opin Anaesthesiol
. 2025 Feb;
38(2):120-128.
PMID: 39937029
Purpose Of This Review: To provide evidence for the use of prothrombin complex concentrate (PCC) as a potential hemostatic treatment for trauma-induced coagulopathy with and without anticoagulants. Recent Findings: PCC...
3.
Witzdam L, Sandhu S, Shin S, Hong Y, Kamal S, Grottke O, et al.
Macromol Biosci
. 2025 Jan;
e2400530.
PMID: 39803823
Blood-contacting medical devices, especially extracorporeal membrane oxygenators (ECMOs), are highly susceptible to surface-induced coagulation because of their extensive surface area. This can compromise device functionality and lead to life-threatening complications....
4.
Grottke O, Fries D
Anasthesiol Intensivmed Notfallmed Schmerzther
. 2025 Jan;
60(1):25-34.
PMID: 39778585
After severe trauma, but also perioperatively, massive bleeding is associated with increased morbidity and mortality. In severely injured patients, hemorrhagic shock remains to be the main cause of death in...
5.
Wienhold J, Rossaint R, Vandeput E, Grottke O
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597850
Andexanet alfa is a specific antidote for factor Xa (FXa) inhibitors. It is licensed to treat patients under FXa inhibitor therapy with life-threatening bleeding. Concomitantly, volume expanders are used to...
6.
von Heymann C, Afshari A, Ahmed A, Arnaoutoglou E, Bolliger D, Fenger-Eriksen C, et al.
Eur J Anaesthesiol
. 2024 Nov;
41(11):867-868.
PMID: 39514740
No abstract available.
7.
Mora L, Maegele M, Grottke O, Koster A, Stein P, Levy J, et al.
Anesthesiology
. 2024 Oct;
142(2):351-363.
PMID: 39476104
No abstract available.
8.
Heubner L, Grottke O, Vicent O, Spieth P, Beyer-Westendorf J
Thromb J
. 2024 Oct;
22(1):89.
PMID: 39379995
Bleeding events in patients receiving direct oral anticoagulation (DOAC) can be life-threatening even at therapeutic DOAC plasma concentrations, as anticoagulation impairs hemostasis and should therefore be identified immediately after hospital...
9.
Wienhold J, Grottke O
Anaesthesiologie
. 2024 May;
73(6):421-422.
PMID: 38727806
No abstract available.
10.
Grottke O, Afshari A, Ahmed A, Arnaoutoglou E, Bolliger D, Fenger-Eriksen C, et al.
Eur J Anaesthesiol
. 2024 Apr;
41(5):327-350.
PMID: 38567679
Background: Anticoagulation is essential for the treatment and prevention of thromboembolic events. Current guidelines recommend direct oral anticoagulants (DOACs) over vitamin K antagonists in DOAC-eligible patients. The major complication of...